3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Glioma
2
Glioblastoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Ductal Adenocarcinoma
1
Osteoradionecrosis
1
Mouth Neoplasms
1
Melanoma
1
Hereditary leiomyomatosis and renal cell cancer
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Ependymoma
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
tocilizumab
2
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
talquetamab
1
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Gemcitabine
1
Dexamethasone
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Contrast Media
×
1 year
×
Clear all
No trials found.